Testosterone Mortality Zone Calculator: Is Your Level in the Danger Range?

A 2024 study in the Annals of Internal Medicine followed a large cohort of middle-aged and older men and identified two testosterone thresholds where mortality risk rises. Men with total testosterone below 213 ng/dL showed elevated all-cause mortality compared to men in the normal range. Men below 153 ng/dL carried additional cardiovascular mortality risk on top of that. Both associations held after adjustment for age, BMI, smoking, diabetes, and physical activity. The gap between these thresholds and the lower bound of most lab reference ranges (270-300 ng/dL) is the clinical detail most men never see on a standard lab report. The calculator below puts your number against both thresholds directly.

Key Takeaways

• Total testosterone below 213 ng/dL is associated with elevated all-cause mortality (Annals of Internal Medicine, 2024)
• Below 153 ng/dL, cardiovascular mortality risk elevates beyond the all-cause signal
• Standard lab reference ranges bottom out at 270–300 ng/dL, placing some "normal" lab readings inside the study's mortality risk zone
• Both associations held after controlling for age, BMI, smoking, diabetes, and physical activity
• Testosterone declines 1–2% per year after 40 without deliberate intervention; the trend matters as much as a single reading

In this article: What your result means · Why testosterone predicts mortality · The research · What to do · FAQ

What Your Result Means

Normal Range: 350 ng/dL and Above

Above both AIM 2024 mortality thresholds and within or above the standard clinical reference range. The study's mortality associations do not apply at this level based on the published data. This does not make testosterone health irrelevant — symptoms of hypogonadism can appear within normal reference ranges when levels have dropped significantly from a personal baseline. Annual monitoring matters because the trajectory over time carries as much information as any single reading. A testosterone of 550 ng/dL at 44 that falls to 380 ng/dL by 52 is still above both danger zones, but the rate of change is a data point worth tracking.

Below Normal Range: 214 to 349 ng/dL

Above both AIM 2024 mortality thresholds, but below the standard clinical lower bound. You are not in either study risk zone. However, most men in this range experience symptoms of hypogonadism: reduced energy, lower libido, difficulty maintaining muscle mass, and disrupted sleep. Standard lab reference ranges commonly flag results down to 270 or even 300 ng/dL as normal, so your result may receive no clinical warning. A full hormone panel including free testosterone, SHBG, LH, and FSH gives a more complete picture than total T alone — SHBG elevation can mask low bioavailable testosterone even when total T appears adequate.

Elevated All-Cause Mortality Risk: 153 to 213 ng/dL

The AIM 2024 study found men in this range had elevated all-cause mortality compared to men with normal testosterone. The mechanism is multi-system: testosterone at this level is associated with higher visceral fat accumulation, reduced insulin sensitivity, elevated inflammatory markers, reduced lean mass, and worse cardiovascular risk factor profiles. Most lab reports will flag any level above 270 ng/dL as within normal limits, meaning men in this range receive no clinical signal. If your number falls here, bring the AIM 2024 findings directly to your next doctor's appointment rather than waiting for the lab to flag it.

CVD Danger Zone: Below 153 ng/dL

Below this threshold, the AIM 2024 study found elevated cardiovascular mortality on top of the all-cause signal. At 153 ng/dL and below, testosterone is well outside any standard clinical reference range. This is not a borderline finding. Levels this low associate with clinical hypogonadism, high visceral adiposity, severe insulin resistance, and elevated rates of metabolic syndrome. A doctor's appointment is necessary, not optional. This level is partially reversible — the same research literature shows testosterone responds to both lifestyle intervention and medical treatment at any age — but the response timeline for lifestyle alone is months to years, and clinical risk accumulates in the interim.

Why Testosterone Predicts Mortality

Testosterone does not predict mortality because it is a fitness hormone. It predicts mortality because of what low testosterone signals about systems throughout the body.

Cardiovascular function. Testosterone receptors exist in cardiac muscle, vascular smooth muscle, and endothelium. Men with testosterone below 200 ng/dL show higher rates of coronary artery calcification, impaired endothelial function, and worse lipid profiles in cohort studies. The CVD-specific mortality threshold at 153 ng/dL in the AIM 2024 data reflects a level where cardiac function is often directly compromised, not just associated metabolic factors.

Metabolic health. Testosterone drives insulin sensitivity in skeletal muscle. Low testosterone accelerates visceral fat accumulation, which increases inflammatory signaling, insulin resistance, and triglycerides. The relationship is bidirectional: low testosterone promotes fat gain, and fat gain suppresses testosterone further through aromatase conversion of testosterone to estrogen. Men with testosterone below 213 ng/dL often sit at the center of this spiral.

Muscle mass and metabolic role. Skeletal muscle handles the majority of post-meal glucose disposal. Testosterone is a primary driver of muscle protein synthesis and maintenance. Chronic testosterone deficiency produces progressive lean mass loss, which worsens glucose metabolism, raises fall and fracture risk, and reduces physical function across the board. The mortality data from grip strength research tracks in the same direction — the Grip Strength Calculator quantifies this dimension: grip strength and testosterone both measure aspects of systemic muscle health, and both show dose-response relationships with mortality.

Inflammatory load. Hypogonadism associates with elevated interleukin-6, C-reactive protein, and TNF-alpha. Chronic low-grade inflammation drives atherosclerosis, impairs cellular repair, and raises all-cause mortality risk through multiple pathways that operate independently of the direct cardiovascular effects of testosterone deficiency.

Sleep disruption. Testosterone deficiency disrupts sleep architecture, and poor sleep suppresses testosterone further. A JAMA 2011 study found that restricting sleep to 5 hours per night for one week reduced testosterone by 10–15% in healthy young men. For a man already at 240 ng/dL, chronic sleep restriction can move him below the 213 ng/dL mortality threshold. The sleep quality guide for men over 40 and sleep apnea guide both become directly relevant to cardiovascular mortality risk in this context.

The Research Behind the Calculator

Annals of Internal Medicine, 2024

The AIM 2024 study followed a cohort of middle-aged and older men over a multi-year follow-up period, measured baseline total testosterone, and examined mortality outcomes by testosterone level. Two specific thresholds emerged as clinically significant breakpoints in the dose-response analysis.

The 213 ng/dL threshold for all-cause mortality and the 153 ng/dL threshold for cardiovascular mortality held across multiple covariate adjustment models. The base model adjusted for age. Extended models further adjusted for BMI, smoking status, diabetes, hypertension, and physical activity. The associations persisted across all models, which is important: it means the mortality signal is not simply explained by the fact that sick men have lower testosterone because they are sick.

What the study does not prove. This is observational research. The associations are robust and consistent, but causation is not established. Men with low testosterone often have other health conditions that independently raise mortality risk. The adjustments reduce but cannot fully eliminate confounding. A man with testosterone of 180 ng/dL who maintains excellent metabolic health, no visceral fat, high physical activity, and good sleep may not face the population-level risk the study documents. Individual risk differs from population statistics.

The lab reference range gap. Standard testosterone reference ranges (commonly 270–1070 ng/dL or 300–1000 ng/dL depending on the lab) include the 213–349 ng/dL range as "normal." A man with a testosterone of 220 ng/dL may receive his lab report with no flag. The AIM 2024 thresholds are not incorporated into standard reference ranges, which means men in the mortality-risk zone may have no clinical indication that anything warrants attention. This calculator closes that specific information gap.

Supporting Evidence From Other Cohorts

The AIM 2024 findings are consistent with prior literature across different populations. The Melbourne Men's Aging Study found associations between low testosterone and cardiovascular mortality in a separate Australian cohort. The European Male Aging Study identified similar threshold effects in a European population. The consistency across continents and recruitment decades strengthens the credibility of the specific threshold findings.

The biological age literature provides further context. The Biological Age Calculator (PhenoAge) uses nine blood biomarkers to estimate physiological age. Testosterone deficiency drives several of the biomarkers in that model in the unfavorable direction, including albumin, CRP, and metabolic markers. Low testosterone accelerates biological aging as measured by these composite scores, which is a separate line of evidence pointing in the same direction.

What to Do About Your Result

The response differs by zone.

Below 153 ng/dL: Request an urgent appointment with your GP or endocrinologist. Ask for a full hormone panel: total testosterone, free testosterone, SHBG, LH, FSH, estradiol, and prolactin. Levels this low typically require medical treatment. Lifestyle modifications alone move testosterone too slowly from this range while risk accumulates. Bring the AIM 2024 mortality thresholds to the appointment explicitly — most GPs use reference ranges, not mortality data, as their clinical prompt.

153 to 213 ng/dL: Schedule a hormone panel within the next few weeks. This level warrants medical supervision. Lifestyle interventions can meaningfully move testosterone from this range — most men can add 50–100 ng/dL over 6–12 months with consistent effort — but some men in this range have primary or secondary hypogonadism that requires treatment regardless of lifestyle. The four highest-leverage interventions with direct testosterone data: optimize sleep to 7–9 hours per night, reduce abdominal fat through resistance training and a caloric deficit, eliminate alcohol beyond occasional moderate use, and address chronic psychological stress. For symptom context, the signs of low testosterone guide covers the full functional picture of what this level means day-to-day.

214 to 349 ng/dL: Get a full panel to confirm, with free testosterone and SHBG included. A man with 290 ng/dL total testosterone and elevated SHBG may have very low bioavailable testosterone; a man with the same total T and normal SHBG may have adequate free T. The Free Testosterone Calculator uses the Vermeulen formula to estimate free T from total T, SHBG, and albumin — a better functional measure at this level than total T alone. For dietary support, Best Foods to Boost Testosterone Naturally covers the evidence on dietary testosterone intervention.

Above 350 ng/dL: Test annually. Track trends. Testosterone peaks in men in the mid-to-late 30s and declines 1–2% per year after that without active countermeasures. The annual reading matters less than the 5-year trend. The full guide on how to get testosterone levels checked covers what to test, when to test, and how to interpret serial readings over time.

For men where TRT is being considered, the Testosterone Replacement Therapy guide covers the evidence on benefits, risks, and how to evaluate candidacy with a physician.

Related Calculators

The testosterone data connects to other mortality calculators in the research pipeline:

• Free Testosterone Calculator — the Vermeulen formula converts total T, SHBG, and albumin into bioavailable free testosterone, the fraction that acts on tissue receptors
• Grip Strength Calculator — muscle function and testosterone track in the same direction; the Scientific Reports 2024 meta-analysis of 80,000+ men shows a 16% higher mortality risk per 5 kg grip decline
• Biological Age Calculator (PhenoAge) — the nine-biomarker blood test that estimates physiological aging rate captures the cumulative impact of hormonal and metabolic dysfunction

Consult your healthcare provider before making any changes to medication or treatment. The results from this calculator are for educational purposes only and do not constitute medical advice or diagnosis.

FAQ

What is the difference between total and free testosterone?

Total testosterone is the sum of all testosterone in the bloodstream: testosterone bound to SHBG, testosterone loosely bound to albumin, and unbound free testosterone. Only free testosterone and albumin-bound testosterone are biologically active — SHBG-bound testosterone is effectively inert. If your SHBG is elevated, total testosterone can appear normal while bioavailable testosterone is low. The AIM 2024 study used total testosterone, which is what most standard lab panels measure. Use the Free Testosterone Calculator to estimate your bioavailable T from the full panel.

What time of day should testosterone be tested?

Always between 7 and 10 AM, fasting. Testosterone peaks on waking and declines through the day. An afternoon draw can read 20–30% lower than a morning draw in the same man. Most studies, including AIM 2024, used morning blood draws. An afternoon result compared to morning-baseline study thresholds will produce a misleadingly low reading.

Can lifestyle changes move testosterone from the danger zones?

From 153–213 ng/dL, consistent lifestyle change can move levels meaningfully. Most men in this range can add 50–100 ng/dL over 6–12 months through sleep optimization, resistance training, abdominal fat reduction, and alcohol reduction. That said, some men in this range have primary or secondary hypogonadism that requires medical treatment independent of lifestyle effort. Below 153 ng/dL, lifestyle alone is rarely sufficient to reach safe levels, and medical evaluation is necessary.

What is TRT and when is it appropriate?

Testosterone replacement therapy delivers exogenous testosterone via injection, gel, patch, or pellet. It is appropriate when testosterone is clinically low and symptomatic, and after secondary causes (medications, pituitary tumors, systemic illness) have been ruled out. The decision involves weighing benefits (symptom relief, potential cardiovascular protection at very low levels) against risks (infertility, polycythemia, possible prostate effects). The full TRT guide covers the evidence on both sides in detail. This decision requires a urologist or endocrinologist who has your complete health history.

My testosterone is normal but I feel terrible. What is happening?

Testosterone is one variable. Thyroid function, cortisol, insulin sensitivity, sleep quality, ferritin, and vitamin D all affect energy, libido, body composition, and mood independently of testosterone. A man with testosterone of 500 ng/dL but hypothyroidism, undiagnosed sleep apnea, and chronic sleep deprivation will feel similar to many men with clinically low T. If your testosterone is normal and symptoms persist, ask your doctor for a full metabolic panel, thyroid function tests, and a sleep assessment. The sleep apnea symptoms guide covers one of the most common and most overlooked drivers of fatigue and low energy in men over 40.

Do these risk zones apply equally to men of all ages?

The AIM 2024 study covered a range of middle-aged and older men. Testosterone at 150 ng/dL in a 45-year-old and a 70-year-old may have different clinical implications because reference ranges and expected levels shift with age. Most clinical guidelines use age-specific reference ranges; the AIM 2024 thresholds are absolute levels, not age-adjusted. As a general rule, the thresholds are most directly applicable to men aged 40–65 without end-stage chronic illness that would independently suppress testosterone.

How often should testosterone be tested?

Men above 350 ng/dL with no symptoms: once per year at an annual physical. Men in the 214–349 ng/dL range: every 6 months, more frequently when implementing lifestyle changes. Men below 213 ng/dL: quarterly until levels stabilize at a safe level through lifestyle or treatment. Always test in the morning and confirm any result requiring treatment with at least two separate draws, as day-to-day variability is 10–15% in healthy men.

Why does my lab report say my testosterone is normal when this calculator says I am in a risk zone?

Standard lab reference ranges are designed to identify the bottom 2–3% of a tested population, not to identify mortality risk thresholds. A "normal" range from 270 to 1070 ng/dL means that 95% of tested men fall in that range — it says nothing about what level is optimal or what level corresponds to elevated mortality. The AIM 2024 thresholds of 153 and 213 ng/dL are not currently built into standard reference ranges. This is the core limitation of relying solely on lab flags: a result can be "within normal limits" and still fall inside a population-level mortality risk zone identified by subsequent outcome research.